Clinical Trials Directory

Trials / Completed

CompletedNCT04677738

Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
Morinaga Milk Industry Co., LTD · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

Overweight has become a critical issue in North America and the market value of weight loss products is expected to rise as the population becomes more health-conscious and aware of the risks associated with excess body weight. This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterium breve supplementation with exercise intervention on fat loss.

Detailed description

In early adulthood, excess body weight is a risk factor associated with several health complications later on in life and probiotics have been used for decades for maintaining intestinal health, and in recent years probiotics have been proposed for weight management. This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterium breve supplementation with exercise intervention on fat loss.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB. breve strainProbiotic capsule. Participants will be instructed to take 2 capsules of placebo for 4 weeks during the run-in period. On day 1 participants will be instructed to take 2 capsules of B. breve strain in the morning before breakfast for 12 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo capsule. Participants will be instructed to take 2 capsules of placebo for 4 weeks during the run-in period. On day 1 participants will be instructed to take 2 capsules of placebo in the morning before breakfast for 12 weeks.

Timeline

Start date
2020-08-20
Primary completion
2024-01-05
Completion
2024-01-05
First posted
2020-12-21
Last updated
2025-10-20
Results posted
2025-03-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04677738. Inclusion in this directory is not an endorsement.